Recent research linking statin heart drugs with Parkinson’s disease has led to an investigation involving tens of thousands of new patients. Researchers in the US are sufficiently troubled by the potential link that they will launch a full trial involving upwards of 16,000 participants. If the link is proven, it will cause a major shift in the manner in which heart related issues such as high cholesterol are treated.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.